GW Pharmaceuticals PLC Posting of Shareholder Circular (2213N)

TIDMGWP

RNS Number : 2213N

GW Pharmaceuticals PLC

21 October 2016

GW Pharmaceuticals plc

Posting of Shareholder Circular

London, UK, 21 October 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, confirms that further to the announcement made on 19 October, a circular has been published and has been posted to shareholders in relation to the Company's intention to cancel the admission of its 0.1 pence ordinary shares to trading on AIM on 5 December, 2016.

A copy of the Circular is available on the Company's website at the following URL: http://www.gwpharm.com.

Enquiries:

 
 GW Pharmaceuticals plc 
 Stephen Schultz, VP Investor        917 280 2424 / 401 500 
  Relations (U.S.)                    6570 
 
 FTI Consulting (Media Enquiries) 
 Ben Atwell / Simon Conway           +44 20 3727 1000 
 
  Peel Hunt LLP (UK NOMAD) 
 James Steel                         +44 20 7418 8900

This information is provided by RNS

The company news service from the London Stock Exchange

END

CIREASEFADDKFFF

(END) Dow Jones Newswires

October 21, 2016 11:37 ET (15:37 GMT)

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Nov 2024 to Dec 2024